C. Polman

1.9k total citations · 1 hit paper
17 papers, 1.4k citations indexed

About

C. Polman is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Oncology. According to data from OpenAlex, C. Polman has authored 17 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pathology and Forensic Medicine, 4 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in C. Polman's work include Multiple Sclerosis Research Studies (13 papers), Systemic Lupus Erythematosus Research (3 papers) and Polyomavirus and related diseases (2 papers). C. Polman is often cited by papers focused on Multiple Sclerosis Research Studies (13 papers), Systemic Lupus Erythematosus Research (3 papers) and Polyomavirus and related diseases (2 papers). C. Polman collaborates with scholars based in Netherlands, Switzerland and United Kingdom. C. Polman's co-authors include Frederik Barkhof, Bob W. van Oosten, L. Truyen, Hans‐Peter Hartung, Jan Boringa, J. Woody, B. Mary E. von Blomberg, Frits W. Bertelsmann, O. R. Hommes and J.H.T.M. van Waesberghe and has published in prestigious journals such as Neurology, Journal of the Neurological Sciences and American Journal of Neuroradiology.

In The Last Decade

C. Polman

16 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2

1996 562 citations Bob W. van Oosten, Frederik Barkhof et al. Neurology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C. Polman Netherlands	10	1.0k	419	374	284	243	17	1.4k
John Thorpe United Kingdom	19	1.2k 1.2×	338 0.8×	481 1.3×	230 0.8×	385 1.6×	29	1.7k
C. Bash United States	17	890 0.9×	337 0.8×	278 0.7×	272 1.0×	113 0.5×	21	1.2k
Siegrid Strasser‐Fuchs Austria	17	820 0.8×	285 0.7×	406 1.1×	235 0.8×	402 1.7×	32	1.5k
Leonora Fisniku United Kingdom	9	1.2k 1.1×	398 0.9×	432 1.2×	123 0.4×	182 0.7×	14	1.3k
M.A.A. van Walderveen Netherlands	7	1.2k 1.2×	327 0.8×	449 1.2×	98 0.3×	349 1.4×	9	1.4k
Josephine Swanton United Kingdom	17	1.2k 1.2×	450 1.1×	611 1.6×	90 0.3×	152 0.6×	21	1.4k
P A Brex United Kingdom	15	1.7k 1.6×	575 1.4×	737 2.0×	80 0.3×	290 1.2×	25	1.9k
S. Anand Trip United Kingdom	17	1.2k 1.2×	386 0.9×	430 1.1×	150 0.5×	306 1.3×	34	1.8k
Kryshani Fernando United Kingdom	14	967 1.0×	320 0.8×	434 1.2×	67 0.2×	236 1.0×	18	1.2k
P. D. Molyneux United Kingdom	13	789 0.8×	300 0.7×	362 1.0×	62 0.2×	174 0.7×	16	980

Countries citing papers authored by C. Polman

Since Specialization

Citations

This map shows the geographic impact of C. Polman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Polman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Polman more than expected).

Fields of papers citing papers by C. Polman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Polman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Polman. The network helps show where C. Polman may publish in the future.

Co-authorship network of co-authors of C. Polman

This figure shows the co-authorship network connecting the top 25 collaborators of C. Polman. A scholar is included among the top collaborators of C. Polman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Polman. C. Polman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Pohl, Christoph, Mike P. Wattjes, Hanneke E. Hulst, et al.. (2013). Interferon beta-1b reduces black holes in a randomised trial of clinically isolated syndrome. Multiple Sclerosis Journal. 20(2). 234–242. 17 indexed citations

Polman, C., Eva Havrdová, Christian Confavreux, & Richard A. Rudick. (2012). Relationship between Timed 25-Foot Walk Walking Speed and Health-Related Quality of Life in AFFIRM and SENTINEL (P07.097). Neurology. 78(Meeting Abstracts 1). P07.097–P07.097. 2 indexed citations

Kappos, Ludwig, Xavier Montalbán, C. Polman, et al.. (2011). Long-term effect of early treatment with interferon-beta-1b after a first clinical event suggestive of multiple sclerosis: 8-year observational extension of the phase 3 BENEFIT trial. UCL Discovery (University College London). 1 indexed citations

Hartung, HP, Ludwig Kappos, C. Polman, et al.. (2007). Betaferon (R)/betaseron (R) in newly emerging multiple sclerosis for initial treatment (benefit): Effects of early vs. delayed treatment with interferon beta-1B. UCL Discovery (University College London).

Kühle, Jens, et al.. (2004). 8 year follow-up of the European study of Interferon beta-1b (EUSPMS) in secondary progressive MS. UCL Discovery (University College London). 3 indexed citations

Polman, C., Frederik Barkhof, Ludwig Kappos, et al.. (2003). Oral interferon beta-1a in relapsing-remitting multiple sclerosis: a double-blind randomized study. Multiple Sclerosis Journal. 9(4). 342–348. 32 indexed citations

Inglese, Matilde, J.H.T.M. van Waesberghe, Marco Rovaris, et al.. (2003). The effect of interferon β-1b on quantities derived from MT MRI in secondary progressive MS. Neurology. 60(5). 853–860. 59 indexed citations

Brex, P A, P. D. Molyneux, Frederik Barkhof, et al.. (2001). The effect of IFNβ-1b on the evolution of enhancing lesions in secondary progressive MS. Neurology. 57(12). 2185–2190. 48 indexed citations

Nijeholt, Geert J. Lycklama à, Jonas A. Castelijns, R.H.C. Lazeron, et al.. (2000). Magnetization Transfer Ratio of the Spinal Cord in Multiple Sclerosis: Relationship to Atrophy and Neurologic Disability. Journal of Neuroimaging. 10(2). 67–72. 39 indexed citations

10.

Waesberghe, Jan Hein van, Marianne AA van Walderveen, J.A. Castelijns, et al.. (1998). Patterns of lesion development in multiple sclerosis: longitudinal observations with T1-weighted spin-echo and magnetization transfer MR.. American Journal of Neuroradiology. 19(4). 675–83. 216 indexed citations

11.

Barkhof, Frederik, M. W. Tas, Jacob Valk, et al.. (1998). Functional correlates of callosal atrophy in relapsing-remitting multiple sclerosis patients. A preliminary MRI study. Journal of Neurology. 245(3). 153–158. 57 indexed citations

12.

Oosten, Bob W. van, Bernard M.J. Uitdehaag, Frederik Barkhof, et al.. (1997). Interleukin-2 therapy does not exacerbate multiple sclerosis. Neurology. 49(2). 633–634. 2 indexed citations

13.

Miller, D. H., C. Polman, Carlo Pozzilli, et al.. (1997). 4-31-17 MRI protocol for the European trial of beta interferon-1b in secondary progressive multiple sclerosis. Journal of the Neurological Sciences. 150. S251–S251. 2 indexed citations

14.

Truyen, L., J.H.T.M. van Waesberghe, M.A.A. van Walderveen, et al.. (1996). Accumulation of hypointense lesions ("black holes") on T ₁ spin-echo MRI correlates with disease progression in multiple sclerosis. Neurology. 47(6). 1469–1476. 378 indexed citations

15.

Oosten, Bob W. van, Frederik Barkhof, L. Truyen, et al.. (1996). Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2. Neurology. 47(6). 1531–1534. 562 indexed citations breakdown →

16.

Diemen, H.A.M. van, et al.. (1992). Increased Visual Impairment after Exercise (Uhthoff’s Phenomenon) in Multiple Sclerosis: Therapeutic Possibilities. European Neurology. 32(4). 231–234. 26 indexed citations

17.

Polman, C., C.D. Dijkstra, Corline J.A. De Groot, J.C. Koetsier, & T. Sminia. (1987). Presence of Ia-Positive Cells in the Central Nervous System of the Rat during Various Pathological Conditions. International Archives of Allergy and Immunology. 83(1). 109–111. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact